Susannah-Graham_Sanjeev-Kumar

Dr Susannah Graham & Dr Sanjeev Kumar

Dr Susannah Graham is a specialist general surgeon with subspecialty training in breast and endocrine surgery. She has experience and expertise in the use of oncoplastic techniques for the treatment of breast cancer. Dr Graham holds VMO appointments at Chris O’Brien Lifehouse, St George Private Hospital, Kareena Private Hospital and Kingsway Day Surgery. She is also a full member of Breast Surgeons of Australia and New Zealand, the specialty society for surgeons treating breast cancer.

Dr Sanjeev Kumar is a Medical Oncologist and Clinician Scientist who grew up in country NSW, before completing undergraduate medical studies at the University of New South Wales in 2006. He trained as a Medical Oncologist at Royal Prince Alfred Hospital, the Chris O’Brien Lifehouse and in the United Kingdom. Sanjeev moved to Cambridge (UK) in 2015 to undertake a fellowship in the Addenbrooke’s Hospital Cancer Drug Development Unit. He was then awarded a University of Cambridge scholarship in 2016 to complete a cancer molecular biology PhD at the Cancer Research UK Cambridge Institute, with a focus on Oestrogen receptor-positive breast cancer. Simultaneously, he ran a UK-wide clinical trial for patients with ER-positive breast cancer. Dr Kumar has returned to Australia to continue his clinical and academic focus on breast cancer with positions at Lifehouse, The Kinghorn Cancer Centre and the Garvan Institute of Medical Research.

More from this expert

Dr Susannah Graham and Dr Sanjeev Kumar unpack the practicalities of adjuvant endocrine therapy after breast cancer, from drug choice and duration to balancing benefit against toxicity.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.